Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tina M Schnoeder

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Molecular & Cellular Oncology|April 15, 2021
A JAK of all trades: how global phosphoproteomics reveal the Achilles heel of MPNsTina M Schnoeder, Florian Perner, Florian H Heidel
Journal of Cancer Research and Clinical Oncology|March 29, 2022
Context-specific effects of NOX4 inactivation in acute myeloid leukemia (AML)Muhammed Burak Demircan, Tina M Schnoeder, Peter C Mgbecheta, et al.
Journal of Hematology & Oncology|June 14, 2013
Rapid induction of complete molecular remission by sequential therapy with LDAC and sorafenib in FLT3-ITD-positive patients unfit for intensive treatment: two cases and review of the literatureDenise Wolleschak, Enrico Schalk, Christian Krogel, et al.
Antioxidants (Basel, Switzerland)|March 25, 2022
Combined Activity of the Redox-Modulating Compound Setanaxib (GKT137831) with Cytotoxic Agents in the Killing of Acute Myeloid Leukemia CellsMuhammed Burak Demircan, Peter C Mgbecheta, Anne Kresinsky, et al.
Leukemia|February 23, 2018
The cell fate determinant Scribble is required for maintenance of hematopoietic stem cell functionJuliane Mohr, Banaja P Dash, Tina M Schnoeder, et al.
Leukemia|February 4, 2023
Cre recombinase expression cooperates with homozygous FLT3 internal tandem duplication knockin mouse model to induce acute myeloid leukemiaJasmin Straube, Theresa Eifert, Therese Vu, et al.
Leukemia|August 16, 2023
Cell fate determinant Llgl1 is required for propagation of acute myeloid leukemiaTheresa Eifert, Chen-Jen Hsu, Alicia L Becker, et al.
Leukemia|September 1, 2021
YBX1 mediates translation of oncogenic transcripts to control cell competition in AMLFlorian Perner, Tina M Schnoeder, Yijun Xiong, et al.
The Journal of Clinical Investigation|July 20, 2018
JAK2-V617F promotes venous thrombosis through β1/β2 integrin activationBärbel Edelmann, Nibedita Gupta, Tina M Schnoeder, et al.
Molecular Cancer|December 4, 2023
Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemiaNuria Tubío-Santamaría, Ashok Kumar Jayavelu, Tina M Schnoeder, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Molecular & Cellular Oncology|April 15, 2021
A JAK of all trades: how global phosphoproteomics reveal the Achilles heel of MPNsTina M Schnoeder, Florian Perner, Florian H Heidel
Journal of Cancer Research and Clinical Oncology|March 29, 2022
Context-specific effects of NOX4 inactivation in acute myeloid leukemia (AML)Muhammed Burak Demircan, Tina M Schnoeder, Peter C Mgbecheta, et al.
Journal of Hematology & Oncology|June 14, 2013
Rapid induction of complete molecular remission by sequential therapy with LDAC and sorafenib in FLT3-ITD-positive patients unfit for intensive treatment: two cases and review of the literatureDenise Wolleschak, Enrico Schalk, Christian Krogel, et al.
Antioxidants (Basel, Switzerland)|March 25, 2022
Combined Activity of the Redox-Modulating Compound Setanaxib (GKT137831) with Cytotoxic Agents in the Killing of Acute Myeloid Leukemia CellsMuhammed Burak Demircan, Peter C Mgbecheta, Anne Kresinsky, et al.
Leukemia|February 23, 2018
The cell fate determinant Scribble is required for maintenance of hematopoietic stem cell functionJuliane Mohr, Banaja P Dash, Tina M Schnoeder, et al.
Leukemia|February 4, 2023
Cre recombinase expression cooperates with homozygous FLT3 internal tandem duplication knockin mouse model to induce acute myeloid leukemiaJasmin Straube, Theresa Eifert, Therese Vu, et al.
Leukemia|August 16, 2023
Cell fate determinant Llgl1 is required for propagation of acute myeloid leukemiaTheresa Eifert, Chen-Jen Hsu, Alicia L Becker, et al.
Leukemia|September 1, 2021
YBX1 mediates translation of oncogenic transcripts to control cell competition in AMLFlorian Perner, Tina M Schnoeder, Yijun Xiong, et al.
The Journal of Clinical Investigation|July 20, 2018
JAK2-V617F promotes venous thrombosis through β1/β2 integrin activationBärbel Edelmann, Nibedita Gupta, Tina M Schnoeder, et al.
Molecular Cancer|December 4, 2023
Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemiaNuria Tubío-Santamaría, Ashok Kumar Jayavelu, Tina M Schnoeder, et al.
Pageof 2